Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...

A technology that diagnoses diseases such as Alzheimer’s and Parkinson’s using just a few drops of blood from a finger prick ...

As prevention trials for Alzheimer’s disease ramp up, researchers need fast and cheap ways to diagnose early, and to screen cognitively normal people. PET is expensive. Cerebrospinal fluid (CSF) ...

As the world’s population ages, health experts are bracing for higher rates of age-related diseases, including Alzheimer’s. Finding new ways to diagnose the condition is more of a priority than ever, ...

The second question, is does any additional diagnostic accuracy provided by the CSF test matter? In clinical practice, a laboratory test that confirmed Alzheimer's disease would remove ambiguity in ...

As of 2023, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer’s disease, according to the Alzheimer’s Association. With that number projected to more than double to 13.8 ...

The first generation of CSF biomarkers for Alzheimer disease comprises those that measure the component proteins of the disease’s signature pathologic lesions. They have been explored for almost 15 ...